412374001: Haemophilus influenzae type b vaccine (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2467826010 Haemophilus influenzae type b vaccine (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

2473954019 Haemophilus influenzae type b vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

4203971000005114 vaccine mod Haemophilus influenzae type B da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
vaccine mod Haemophilus influenzae type B	Is a	vaccine mod influenzavirus	false	Inferred relationship	Some
vaccine mod Haemophilus influenzae type B	Is a	Drug allergen	false	Inferred relationship	Some
vaccine mod Haemophilus influenzae type B	Is a	bakterievaccine	false	Inferred relationship	Some
vaccine mod Haemophilus influenzae type B	Is a	Influenza vaccine	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
difteri- + kighoste- + tetanus- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae type B (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas + fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Haemophilus influenzae type B (Hib)- + difteri- + tetanus- + kighostevaccine i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Haemophilus influenzae type b (Hib)-/difteri-/tetanus-/kighostevaccine hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Haemophilus influenzae type B-vaccine pulver til injektionsvæske, rekonstitution + solvens	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
difteri- + tetanus- + kighoste- + polio- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	3
difteri-/tetanus-/kighoste-/polio-/Haemophilus influenzae type B-vaccine hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Haemophilus influenzae type b-polysaccharidvaccine, konjugeret (difteritoxoidkonjugat)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae type b-oligosaccharidvaccine, konjugeret (difteri CRM>197< proteinkonjugeret)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Diphtheria and tetanus toxoid 0.5vial/haemophilus b conjugate injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of third dose of Haemophilus influenzae type b vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
forgiftning med Haemophilus influenzae type b-vaccine	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
accidentel forgiftning med Haemophilus influenzae type B-vaccine	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
tilsigtet forgiftning med Haemophilus influenzae type b-vaccine	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
forgiftning med Haemophilus influenzae type B-vaccine, uvist med hvilken hensigt	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Adverse reaction to component of vaccine product containing Haemophilus influenzae type b antigen (disorder)	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Allergy to Haemophilus influenzae type b vaccine	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae type b + meningokok gruppe C-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae type b + rekombinant hepatitis B-virus-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae type b 7,5 µg + rekombinant hepatitis B-virusoverfladeantigen 5 µg injektionsvæske, opløsning, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Haemophilus influenzae type B- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae type b-polysaccharidvaccine 10 µg + tetanustoxoid 30 µg pulver til injektionsvæske, opløsning, hætteglas + solvens	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus- + rekombinant Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	3
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of Haemophilus influenzae type b and meningitis C vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
difteri- + tetanus- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of Haemophilus influenzae type b and meningitis C vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of third dose of Haemophilus influenzae type b vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of third dose of Haemophilus influenzae type b vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Allergy to Haemophilus influenzae type b vaccine	Causative agent	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine/Hepatitis B Surface Antigen Vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	4
Administration of first dose of Haemophilus influenzae type b and meningitis C vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	4
Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	5
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of first dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	3
Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	3
Haemophilus influenzae type b 7,5 µg + rekombinant hepatitis B-virusoverfladeantigen 5 µg injektionsvæske, opløsning, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Vaccination for diphtheria, pertussis, tetanus, poliomyelitis, Hepatitis B virus and Haemophilus influenzae type b	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	3
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	1
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2
Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	vaccine mod Haemophilus influenzae type B	Inferred relationship	Some	2

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467826010	Haemophilus influenzae type b vaccine (substance)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
2473954019	Haemophilus influenzae type b vaccine	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
4203971000005114	vaccine mod Haemophilus influenzae type B	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)